The report on global biosimilars market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research done by the analysts. The study extensively provides the market share, growth, trends and forecasts for the period 2016-2022. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).
Major Drivers |
Major Restraints |
- Rising incidences of diseases
- Increasing government support
- Rise in aging population
|
- High manufacturing complexities and costs
- Innovative strategies by biologic drug manufacturers
|
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
The report classifies the market into different segments based on type of product and application. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
Geographical Leader |
Leading Segments |
|
- By Type of Product - Recombinant Glycosylated Proteins
- By Application - Oncology
|
The report also covers the complete competitive landscape of the global Biosimilars market with company profiles of key players such as:
- Hospira, Inc.
- Roche Diagnostics
- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
- Amgen
- Biocon Ltd.
- Dr. Reddy's Laboratories
- Celltrion, Inc.
- Mylan, Inc.
- Merck KGAA
A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
SEGMENTATIONS IN THE REPORT:
By Type of Product:
- Recombinant Non-Glycosylated Proteins00000
- Insulin
- Recombinant Human Growth Hormone (RHGH)
- Granulocyte Colony-Stimulating Factor (Filgrastim)
- Interferons
- Recombinant Glycosylated Proteins
- Erythropoietin (EPO)
- Monoclonal Antibodies (MABS)
- Follitropin
- Recombinant Peptides
By Applications:
- Oncology
- Blood Disorders
- Chronic and Autoimmune Diseases
- Growth Hormone Deficiency
- Infectious Diseases
- Other Applications
By Geography:
- North America
- Europe
- Asia Pacific
- Rest of the World
The Global Biosimilars Market has been exhibited in detail in the following chapters -
Chapter 1 Biosimilars Market Preface
Chapter 2 Executive Summary
Chapter 3 Biosimilars Industry Analysis
Chapter 4 Biosimilars Market Value Chain Analysis
Chapter 5 Biosimilars Market Analysis By Type of Product
Chapter 6 Biosimilars Market Analysis By Applications
Chapter 7 Biosimilars Market Analysis By Geography
Chapter 8 Competitive Landscape Of Biosimilars Companies
Chapter 9 Company Profiles Of Biosimilars Industry
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.